nach oben

Forensic Science, Medicine and Pathology

Erschienen in:

01.12.2012 | Original Article

The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens

verfasst von: Dimitri Gerostamoulos, Jochen Beyer, Voula Staikos, Penny Tayler, Noel Woodford, Olaf H. Drummer

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Postmortem redistribution (PMR) is an accepted toxicological phenomenon that may affect the interpretation of postmortem blood concentrations. The extent of PMR is not well understood for some drugs. This report describes the PMR of selected substances resulting from the analysis of 149 cases comparing blood specimens taken at admission of the deceased to the mortuary and then at autopsy. Blood was collected in preserved tubes containing 1 % sodium fluoride/potassium oxalate. All cases were subject to a full autopsy and blood extracts were analyzed using a targeted screen by LC–MS/MS. 30 drug or drug metabolites that were detected with an incidence of 6 or more were included in this study. The pre-autopsy interval ranged from 0.5 to 164 h (6.4 days) with an average of 64 h for the cases analyzed. The increase in drug concentration from mortuary admission to autopsy ranged from 30 % for drugs such as citalopram, mirtazapine, and sertraline to 300 % for doxylamine. Only 7 drugs of the 30 studied showed increases of greater than 20 % when comparing autopsy to mortuary admission blood irrespective of the length of the postmortem interval. Drugs including methadone, EDDP, fluoxetine, mirtazapine, and sertraline all showed statistically significant increases during the pre-autopsy interval (p < 0.05) while 6-acetylmorphine, 9-hydroxy-risperidone, and caffeine showed significant decreases (p < 0.05) from mortuary admission to autopsy. While femoral blood is thought to reduce PMR, this data shows that for some drugs significant redistribution can occur even when taking peripheral specimens irrespective of the delay in the postmortem interval.

Drummer OH, Gerostamoulos J. Postmortem drug analysis: analytical and toxicological aspects. Ther Drug Monit. 2002;24(2):199–209.PubMedCrossRef

Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol (Phila). 2005;43(4):235–41.

Ferner RE. Postmortem clinical pharmacology. Br J Clin Pharmacol. 2008;66(4):430–43.PubMedCrossRef

Pélissier-Alicot AL, Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol. 2003;27(8):533–44.PubMed

Skopp G. Postmortem toxicology. Forensic Sci Med Pathol. 2010;6(4):314–25.PubMedCrossRef

Jones GR, Pounder DJ. Site dependence of drug concentrations in postmortem blood-a case study. J Anal Toxicol. 1987;11(5):186–90.PubMed

Prouty RW, Anderson WH. A comparison of postmortem heart blood and femoral blood ethyl alcohol concentrations. J Anal Toxicol. 1987;11(5):191–7.PubMed

Kuhlman JJ Jr, Mayes RW, Levine B, Jones R, Wagner GN, Smith ML. Chloroquine distribution in postmortem cases. J Forensic Sci. 1991;36(5):1572–9.PubMed

Hilberg T, Mørland J, Bjørneboe A. Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int. 1994;64(1):47–55.PubMedCrossRef

10.

McIntyre IM, King CV, Cordner SM, Drummer OH. Postmortem clomipramine: therapeutic or toxic concentrations? J Forensic Sci. 1994;39(2):486–93.PubMed

11.

Pounder DJ, Hartley AK, Watmough PJ. Postmortem redistribution and degradation of dothiepin: human case studies and an animal model. Am J Forensic Med Pathol. 1994;15(3):231–5.PubMedCrossRef

12.

Logan BK, Smirnow D. Postmortem distribution and redistribution of morphine in man. J Forensic Sci. 1996;41(2):221–9.PubMed

13.

Pohland RC, Bernhard NR. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac^®). J Forensic Sci. 1997;42(5):812–6.PubMed

14.

Robertson MD, Drummer OH. Postmortem distribution and redistribution of nitrobenzodiazepines in man. J Forensic Sci. 1998;43(1):9–13.PubMed

15.

Barnhart FE, Fogacci JR, Reed DW. Methamphetamine—a study of postmortem redistribution. J Anal Toxicol. 1999;23(1):69–70.PubMed

16.

Couper FJ, Drummer OH. Postmortem stability and interpretation of β2-agonist concentrations. J Forensic Sci. 1999;44(3):523–6.PubMed

17.

Jaffe PD, Batziris HP, van der Hoeven P, et al. A study involving venlafaxine overdoses: comparison of fatal and therapeutic concentrations in postmortem specimens. J Forensic Sci. 1999;44(1):193–6.PubMed

18.

Kunsman GW, Rodriguez R, Rodriguez P. Fluvoxamine distribution in postmortem cases. Am J Forensic Med Pathol. 1999;20(1):78–83.PubMedCrossRef

19.

Gerostamoulos J, Drummer OH. Postmortem redistribution of morphine and its metabolites. J Forensic Sci. 2000;45(4):843–5.PubMed

20.

Kerswill RM, Vicente MR. Clozapine and postmortem redistribution. Am J Psychiatry. 2003;160(1):184.PubMedCrossRef

21.

Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in postmortem cases. Forensic Sci Int. 2006;164(2–3):235–9.PubMedCrossRef

22.

Olson KN, Luckenbill K, Thompson J, Middleton O, Geiselhart R, Mills KM, Kloss J, Apple FS. Postmortem redistribution of fentanyl in blood. Am J Clin Pathol. 2010;133(3):447–53.PubMedCrossRef

23.

Moriya F, Hashimoto Y. Pericardial fluid as an alternative specimen to blood for postmortem toxicological analyses. Legal Med. 1999;1(2):86–94.PubMedCrossRef

24.

Moriya F, Hashimoto Y. Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem. J Forensic Sci. 1999;44(1):10–6.PubMed

25.

Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol. 2005;43(4):235–41.

26.

Pelissier-Alicot AL, Coste N, Bartoli C, Piercecchi-Marti MD, Sanvoisin A, Gouvernet J, Leonetti G. Comparison of ethanol concentrations in right cardiac blood, left cardiac blood and peripheral blood in a series of 30 cases. Forensic Sci Int. 2006;156(1):35–9.PubMedCrossRef

27.

Pok PRP, Haddouche D, Mauras M, Kuhlmann E, Burle J, Salmon T, Berland E, Coiffait PE, Viala A. Cardiac and peripheral blood similarities in the comparison of nordiazepam and bromazepam blood concentrations. J Anal Toxicol. 2008;32(9):782–6.

28.

Drummer OH. Forensic toxicology. EXS. 2010;100:579–603.

29.

Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 1990;35(2):243–70.PubMed

30.

Butzbach DM. The influence of putrefaction and sample storage on postmortem toxicology results. Forensic Sci Med Pathol. 2010;6(1):35–45.PubMedCrossRef

31.

Hearn WL, Keran EE, Huang W, Hime G. Site-dependent postmortem changes in blood cocaine concentrations. J Forensic Sci. 1991;36(3):673–84.PubMed

32.

Saar E, Gerostamoulos D, Dummer OH, et al. Identification and quantification of 30 antipsychotics in blood using LC-MS/MS. J Mass Spectrom. 2010;45(8):915–25.PubMedCrossRef

33.

Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. J Clin Pathol. 2000;53(4):282–5.PubMedCrossRef

34.

Drummer O, Forrest AR, Goldberger B, Karch SB. Forensic science in the dock. BMJ. 2004;329(7467):636–7.PubMedCrossRef

35.

Karch SB. Is postmortem toxicology quackery? J Clin Forensic Med. 2003;10(3):197–8.PubMedCrossRef

36.

Flanagan RJ, Connally G, Evans JM. Analytical toxicology: guidelines for sample collection postmortem. Toxicol Rev. 2005;24(1):63–71.PubMedCrossRef

37.

Forrest AR. ACP Broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses. J Clin Pathol. 1993;46(4):292–6.PubMedCrossRef

38.

Kennedy MC. Postmortem drug concentrations. Intern Med J. 2010;40(3):183–7.PubMedCrossRef

39.

Dinis-Oliveira RJ, Carvalho F, Duarte JA, et al. Collection of biological samples in forensic toxicology. Toxicol Mech Methods. 2010;20(7):363–414.PubMedCrossRef

40.

Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004;142(2–3):101–13.PubMedCrossRef

41.

Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004;142(2–3):75–100.PubMedCrossRef

42.

Drummer OH. Postmortem toxicology. Forensic Sci Int. 2007;165(2–3):199–203.PubMedCrossRef

43.

Hepler BR, Isenschmid DS, Schmidt CJ. postmortem redistribution: practical considerations in death investigation, presented at the American Academy of Forensic Sciences: Dallas: 2004. Abstract K-14.

44.

Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol. 1989;13(5):305–7.PubMed

45.

Rohrig TP, Prouty RW. A nortriptyline death with unusually high tissue concentrations. J Anal Toxicol. 1989;13(5):303–4.PubMed

46.

Anderson DT, Fritz KL, Muto JJ. Distribution of mirtazapine (Remeron) in thirteen postmortem cases. J Anal Toxicol. 1999;23(6):544–8.PubMed

47.

Levine B, Jenkins AJ, Smialek JE. Distribution of sertraline in postmortem cases. J Anal Toxicol. 1994;18(5):272–4.PubMed

48.

Tolliver SSH, Lee W, Furton KG. Evaluating the relationship between postmortem and antemortem morphine and codeine concentrations in whole blood. J Anal Toxicol. 2010;34:491–7.PubMed

49.

Gerostamoulos J, Burke MP, Drummer OH. Involvement of codeine in drug-related deaths. Am J Forensic Med Pathol. 1996;17(4):327–35.PubMedCrossRef

50.

Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363(1–2):1–25.PubMedCrossRef

51.

Karch S. Response to postcard from Sweden. J Forensic Leg Med. 2009;16(8):501–2.PubMedCrossRef

52.

Carroll FT, Marraccini JV, Lewis S, Wright W. Morphine-3-d glucuronide stability in postmortem specimens exposed to bacterial enzymatic hydrolysis. Am J Forensic Med Pathol. 2000;21(4):323–9.PubMedCrossRef

53.

Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1(1):109–18.PubMedCrossRef

54.

Peters FT, Schaefer S, Staack RF, et al. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom. 2003;38(6):659–76.PubMedCrossRef

55.

Holmgren P, Druid H, Holmgren A, et al. Stability of drugs in stored postmortem femoral blood and vitreous humor. J Forensic Sci. 2004;49(4):820–5.PubMedCrossRef

56.

Stevens HM. The stability of some drugs and poisons in putrefying human liver tissues. J Forensic Sci Soc. 1984;24(6):577–89.PubMedCrossRef

57.

Saukko PJ, Knight B. Knight’s forensic pathology. 3rd ed. London: Arnold; 2004.

58.

Robertson MD, Drummer OH. Postmortem drug metabolism by bacteria. J Forensic Sci. 1995;40(3):382–6.PubMed

59.

Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: modeling postmortem redistribution of structurally diverse drugs using multivariate statistics. Forensic Sci Int. 2009;190(1–3):9–15.PubMedCrossRef

60.

Jones GR, Peat MA. Forensic toxicology laboratory guidelines. J Anal Toxicol. 1999;23(7):636.PubMed

61.

Hargrove VM, McCutcheon JR. Comparison of drug concentrations taken from clamped and unclamped femoral vessels. J Anal Toxicol. 2008;32(8):621–5.PubMed

62.

Hilberg T, Bugge A, Beylich KM, Mørland J, Bjørneboe A. Diffusion as a mechanism of postmortem drug redistribution: an experimental study in rats. Int J Legal Med. 1992;105(2):87–91.PubMedCrossRef

63.

Caplehorn JR, Drummer OH. Methadone dose and postmortem blood concentration. Drug Alcohol Rev. 2002;21(4):329–33.PubMedCrossRef

64.

Baselt RC. Disposition of toxic drugs and chemicals in man. 9th ed. Seal Beach: Biomedical Publications; 2011.

Titel: The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens
verfasst von: Dimitri Gerostamoulos
Jochen Beyer
Voula Staikos
Penny Tayler
Noel Woodford
Olaf H. Drummer
Publikationsdatum: 01.12.2012
Verlag: Springer US
Erschienen in: Forensic Science, Medicine and Pathology / Ausgabe 4/2012
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI: https://doi.org/10.1007/s12024-012-9341-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens

Abstract

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Suspected paradoxical undressing in a homicide case

Autoerotic death: a rare but recurrent entity

Comments on complete post-mortem decapitation in suicidal hanging

Lethal gallstone ileus

Duret hemorrhage: demonstration of ruptured paramedian pontine branches of the basilar artery on minimally invasive, whole body postmortem CT angiography

Management of medicolegal natural deaths from hemopericardium or hemothorax using postmortem CT scanning

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren